ArticleMolecular and clinical oncology2026

Cumulative cytotoxic chemotherapy exposure after the introduction of PARP inhibitors in advanced high-grade serous tubo-ovarian and primary peritoneal carcinoma: A descriptive single-center historical cohort study.

Natsuki Osawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.